Evaluation of polymer matrices for an adsorptive approach to plasma detoxification
Joseph A Costanzo1, Courtney A Ober, Richard Black
1Department of Chemical Engineering, University of Virginia, 102 Engineer's Way, Charlottesville, VA 22904, USA.
Abstract:
Acute liver failure arises when potentially toxic metabolites accumulate in the bloodstream because of a breakdown in liver function. New extracorporeal systems combining membrane and adsorbent technologies are being developed to replace critical liver detoxification functions between diagnosis and transplantation. This study addresses the adsorption of representative plasma components on four different hydrophobic, polymeric adsorbents for possible use in an extracorporeal hemodialysis device. The adsorbents considered span a range of pore sizes and include both strongly hydrophobic divinylbenzene (DVB) matrices as well as a less hydrophobic acrylate matrix. Adsorption equilibrium and rate measurements were made for these matrices using human serum albumin (HSA), polyclonal human immunoglobulin G (IgG), and bilirubin (BR), as representative plasma components. Pore size was found to contribute significantly to selectivity. Results demonstrated that strongly hydrophobic materials with pore sizes that allow free access to protein-bound BR are most effective for BR removal whether they are initially clean or pre-saturated with HSA.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Ion Exchange
Analyte Adsorption and Distribution
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis


